Normal weight diabetic patients versus obese diabetics: Relation of overall and abdominal adiposity to vascular health

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Lukich, Alla ^a   Gavish, Dov ^a,b   Shargorodsky, Marina ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN;

ABDOMINAL OBESITY; ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BODY MASS; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PULSE WAVE; SEX DIFFERENCE; SMOKING; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD VESSEL; DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VERY ELDERLY;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PULSE WAVE ANALYSIS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84988614855     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0141-8     Document Type: Article

References (32)

1. Zieman SJ, Melenovsky V, Kass DA: Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25:932-943.
2. Giannattasio C, Mancia G: Arterial distensibility in humans. Modulating mechanisms, alterations in diseases and effects of treatment. J Hypertens 2002, 20:1889-1899.
3. Montagnani M, Quon MJ: Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2000, 2:285-292.
4. Greenfield GR, Samaras K, Chisholm DJ, Campbell LV: Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index). Int J Cardiol 2007, 114:50-56.
5. Suraamornkul S, Kwancharoen R, Ovartlarnporn M, Rawdaree P, Bajaj M: Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients. Metab Syndr Relat Disord 2010, 8(2):113-118.
6. Meneilly GS, Elliott T: Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care 1999, 22:112-118.
7. Liao J, Farmer J: Arterial stiffness as a risk factor for coronary artery disease. Curr Atheroscler Rep 2014, 16(2):387.
8. Van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC: Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke 2001, 32:454-460.
9. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function?. Circulation 2002, 106:2085-2090.
10. O'Rourke M, Staessen JA: Clinical application of arterial stiffness definitions and reference values. Am J Hypertens 2002, 15:426-444.
11. Martínez-González MA, García-Arellano A, Toledo E, Bes-Rastrollo M, Bulló M, Corella D, Fito M, Ros E, Lamuela-Raventós RM, Rekondo J, Gómez-Gracia E, Fiol M, Santos-Lozano JM, Serra-Majem L, Martínez JA, Eguaras S, Sáez-Tormo G, Pintó X, Estruch R: Obesity indexes and total mortality among elderly subjects at high cardiovascular risk: the PREDIMED study. PLoS One 2014, 29:9(7).
12. Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L, Vasorisk group: Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord 2012, 12:3.
13. Cox BD, Whichelow MJ, Prevost AT: The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord 1998, 22:966-973.
14. Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW, Wannamethee SG, Lawlor DA: Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr 2010, 91:547-556.
15. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RBS, O'Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 2007, 116(1):39-48.
16. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA: Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson heart study. J Clin Endocrinol Metab 2010, 95(12):5419-5426.
17. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF Jr, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O'Donnell CJ, Benjamin EJ, Fox CS: Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation 2007, 116(11):1234-1241.
18. Tan KCB, Xu A, Chow WS, Lam MCW, Ai VHG, Tam SCF, Lam KSL: Hypoadiponectinemia is associated with impaired endotheliumdependent vasodilation. J Clin Endocrinol Metab 2004, 89:765-769.
19. Störk S, Bots ML, Angerer P, Schacky C, Grobbee DE, Angermann CE, Seufert J: Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis 2007, 194:e147-e153.
20. Yang R, Barouch LA: Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007, 101:545-559.
21. Protopsaltis I, Foussas S, Angelidi A, Gritzapis A, Sergentanis TN, Matsagos S, Tzirogiannis K, Panoutsopoulos GI, Dimitriadis G, Raptis S, Melidonis A: Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals. Cardiovasc Diabetol 2012, 11:141.
22. Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P: Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001, 38:429-433.
23. Dahlén EM, Tengblad A, Länne T, Clinchy B, Ernerudh J, Nystrom FH, Östgren CJ: Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes. Diabetes Metab 2014, 40(1):76-81.
24. Dahlén EM, Bjarnegård N, Länne T, Nystrom FH, Ostgren CJ: Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes-a prospective observational cohort study. Cardiovasc Diabetol 2013, 12:55.
25. Liang J, Wang Y, Li H, Liu X, Qiu Q, Qi L: Neck circumference and early stage atherosclerosis: the cardiometabolic risk in Chinese (CRC) study. Cardiovasc Diabetol 2014, 13(1):107.
26. Nickenig G, Roling J, Strehlow K, Schnabel P, Bohm M: Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 1998, 98:2453-2460.
27. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
28. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rossei EA: Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001, 103:1238-1244.
29. Hughes TM, Althouse AD, Niemczyk NA, Hawkins MS, Kuipers AL, Sutton-Tyrrell K: Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial. Cardiovasc Diabetol 2012, 11:114.
30. Ikeda U, Takahashi M, Shimada K: C-reactive protein directly inhibits nitric oxid production by cytokine-stimulated vascular smooth muscle cell. J Cardiovasc Pharmacol 2003, 42:607-611.
31. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ: Sself-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106:913-919.
32. Nordstrand N, Gjevestad E, Dinh KN, Hofsø D, Røislien J, Saltvedt E, Os I, Hjelmesæth J: The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC Cardiovasc Disord 2011, 11:7.